CME Spotlight: Medical communications evolves
November 19, 2010CME, CME Spotlight, Continuing medical education, Eugene Pozniak, medical education
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
New Men’s Health journal launched
November 19, 2010Medical Communications Trends in Urology and Men's Health, medical education, men's health
A new controlled circulation journal Trends in Urology and Men’s Health has been launched to help promote doctors’ awareness of …
BTG to buy Biocompatibles
November 19, 2010Research and Development BTG, Biocompatibles
BTG is to pay £156 million to acquire Biocompatibles, the drug-device specialists.Established in 1984 and floated in 1995, Biocompatibles specialises …
Synovate Healthcare appoints Dr Nicole Oehlrich
November 18, 2010Medical Communications, Sales and Marketing Dr Nicole Oehlrich, appointment, medical communications, oncology market research, sales and marketing, synovate
Global market research agency Synovate has appointed Dr Nicole Oehlrich to the role of oncology business consultant for its specialist …
Novartis outlines business strategy
November 18, 2010Research and Development, Sales and Marketing Novartis, business development, pharma strategy
Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …
European pharma expects regulatory compliance challenges
November 18, 2010Sales and Marketing CRM, Cegedim Dendrite, Transparency Directive, regulatory compliance, transparency
European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according …
What would Mad Men make of the digital era?
November 18, 2010Medical Communications Creative Lynx, advertising, digital marketing
Sharp-suited creative director Don Draper from AMC’s television series ‘Mad Men’, in conversation with Creative Lynx’s David Hunt … DAVID: …
Genzyme courting ‘white knight’ bid from Takeda
November 18, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers
Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
CP Pharma gets FDA warning for Wrexham facility
November 18, 2010Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing
UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …
New ABPI Code published
November 17, 2010Medical Communications, Sales and Marketing 2011 ABPI Code, ABPI, ABPI Code of Practice, PMCPA, pharma marketing, pharma sales
The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …
Government directs councils to supply personal health budgets
November 17, 2010Sales and Marketing big society, government, healthcare, reforms
The government announced this week that it expects local councils to provide personal health budgets to a million eligible people …
Roche set to cut 4,800 jobs worldwide
November 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide
Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …
Pfizer establishes new US research network
November 17, 2010Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer
Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …
Government drops Dr Foster Intelligence
November 17, 2010Sales and Marketing Dr Foster Intelligence, White paper, government, reforms
The government is set to drop the public-private partnership it currently has with Dr Foster Intelligence, its key provider information …
Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs
November 17, 2010Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer
A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …
Digital Pharma: Diabetes video goes viral
November 16, 2010Medical Communications, Sales and Marketing Diabetes Hands Foundation, Digital Pharma blog, Roche, diabetes, viral video, youtube
An online video encouraging diabetics to test their blood sugar levels has passed 117,000 views on YouTube in just over …
First patient treated in groundbreaking stem cell trial
November 16, 2010Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke
The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …
FDA approves Eisai breast cancer drug Halaven
November 16, 2010Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer
The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …
PolyTherics appoints Dr John Burt chief business officer
November 16, 2010Manufacturing and Production, Research and Development Dr John Burt, PolyTherics, appointment, manufacturing and production, protein engineering, research and development
UK protein engineering company PolyTherics has appointed Dr John Burt as chief business officer. He was previously chief executive of …
Value-based pricing no ‘magic bullet’ – ABPI
November 16, 2010Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing
UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
